CCA
MDT icon

Cypress Capital Advisors’s Medtronic MDT Stock Holding History

Cypress Capital Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$750K Sell
9,582
-633
-6% -$51.1K 0.31% 46
2026
Q1 		$885K Sell
10,215
-128
-1% -$12.3K 0.48% 39
2025
Q4 		$994K Sell
10,343
-32
-0.3% -$3.11K 0.53% 33
2025
Q3 		$988K Sell
10,375
-522
-5% -$48K 0.56% 32
2025
Q2 		$950K Buy
10,897
+3,919
+56% +$332K 0.59% 34
2025
Q1 		$627K Buy
+6,978
New +$624K 0.44% 47

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Cypress Capital Advisors's MDT Position: Q2 2026 in Review

Cypress Capital Advisors reduced its Medtronic (MDT) stake by 6.2% in Q2 2026, selling an estimated $51.1K and leaving 9,582 shares worth $750K. The position accounts for 0.31% of the portfolio, ranked #46.

Cypress Capital Advisors first reported a position in MDT in Q1 2025 and has held it in 6 quarters since. The position peaked at $994K in Q4 2025. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Cypress Capital Advisors held 9,582 shares of Medtronic worth $750K as of Q2 2026.
  • Cypress Capital Advisors sold 633 Medtronic shares in Q2 2026, an estimated $51.1K.
  • Medtronic made up 0.31% of Cypress Capital Advisors's portfolio in Q2 2026, its #46 holding.
  • Cypress Capital Advisors first reported a position in Medtronic in Q1 2025 and has held it in 6 quarters since.
  • Cypress Capital Advisors's Medtronic position peaked at $994K in Q4 2025.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Cypress Capital Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.